AQP4 and Alzheimer disease: Panel C of Fig. 7 illustrates how tPBM is expected to restore impaired glymphatic function of the human brain by enhancing CSF flow and activating aquaporin-4 (AQP4) channels in astrocytes.(30) This proposed process promotes the clearance of accumulated waste products and neurotoxins, thereby addressing the key pathological features of AD.